Iskit, Alper B <br/><br/>
Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.  [electronic resource] 

 -  Vascular pharmacology  Feb 2007 
 - 129-36 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.vph.2006.08.415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Adenosine Triphosphate--metabolism<br/>Animals<br/>Arrhythmias, Cardiac--etiology<br/>Blood Pressure--drug effects<br/>Carbamates--pharmacology<br/>Cyclohexanes--pharmacology<br/>Disease Models, Animal<br/>Drug Interactions<br/>Endotoxemia--chemically induced<br/>Glyburide--pharmacology<br/>Heart Atria--drug effects<br/>Heart Conduction System--drug effects<br/>Lipopolysaccharides--pharmacology<br/>Male<br/>Myocardial Ischemia--complications<br/>Nateglinide<br/>Phenylalanine--analogs & derivatives<br/>Piperidines--pharmacology<br/>Potassium Channel Blockers--pharmacology<br/>Potassium Channels--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Tachycardia, Ventricular--metabolism<br/>Tetraethylammonium<br/>Time Factors<br/>Ventricular Fibrillation--metabolism<br/>Ventricular Premature Complexes--metabolism